[The clinical observation of serum specific biomarkers in patients with chronic graft-versus-host disease].
T Chen(Army Medical University), Xin-Yun Zhang, X P Li, Lianyin Gao, Cifeng Zhang, Siqiang Yang, Xuemei Peng, Y Liu(Army Medical University), Peiyan Kong(Army Medical University), Qi Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Jaggi Rao(University of Alberta), Rui Wang(Tianjin University of Traditional Chinese Medicine), Yunxuan Feng(Tsinghua University), Liufeng Tang
Cited by 3
Related Papers
Development of Mannosylated Lipid Nanoparticles for mRNA Cancer Vaccine with High Antigen Presentation Efficiency and Immunomodulatory Capability
|Angewandte Chemie International Edition|2024|58
Mesenchymal Stem Cells for Prophylaxis of Chronic Graft-vs-Host Disease After Haploidentical Hematopoietic Stem Cell Transplant
|JAMA Oncology|2023|53